Literature DB >> 19167809

Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition.

Iha Park1, Kwang-Kyun Park, Jung Han Yoon Park, Won-Yoon Chung.   

Abstract

Isoliquiritigenin, a natural flavonoid found in licorice, shallots, and bean sprouts, has been demonstrated to inhibit proliferation and to induce apoptosis in a variety of human cancer cells. We attempted to ascertain the underlying mechanism by which isoliquiritigenin induced cell cycle arrest and cytotoxicity in HeLa human cervical cancer cells. Isoliquiritigenin treatment arrested cells in both G2 and M phase. The cells arrested in interphase (G2) showed markers for DNA damage including the formation of gamma-H2AX foci and the phosphorylation of ATM and Chk2, whereas the cells arrested in M phase evidenced separate poles and mitotic metaphase-like spindles with partially unaligned chromosomes. The induction of DNA damage and blockade at the metaphase/anaphase transition implied that isoliquiritigenin might function as a topoisomerase II poison, which was further demonstrated via an in vitro topoisomerase II inhibition assay. These results show that isoliquiritigenin inhibits topoiosmerase II activity, and the resultant DNA damage and arrest in mitotic metaphase-like stage contributes to the antiproliferative effects of isoliquiritigenin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167809     DOI: 10.1016/j.canlet.2008.12.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

2.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

3.  Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics.

Authors:  Mahmoud Youns; Yu-Jie Fu; Yuan-Gang Zu; Anne Kramer; V Badireenath Konkimalla; Bernhard Radlwimmer; Holger Sültmann; Thomas Efferth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-29       Impact factor: 3.000

Review 4.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

5.  MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.

Authors:  Zhiyu Wang; Neng Wang; Pengxi Liu; Qianjun Chen; Honglin Situ; Ting Xie; Jianxing Zhang; Cheng Peng; Yi Lin; Jianping Chen
Journal:  Oncotarget       Date:  2014-08-30

6.  Preparation, Properties and Preclinical Pharmacokinetics of Low Molecular Weight Heparin-modified Isoliquiritigenin-loaded Solid Lipid Nanoparticle.

Authors:  Xiaoyun Zhang; Hua Qiao; Ying Chen; Lin Li; Huxiong Xia; Yanbin Shi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.

Authors:  Zhiyu Wang; Neng Wang; Shouwei Han; Dongmei Wang; Suilin Mo; Linzhong Yu; Hui Huang; Kamchuen Tsui; Jiangang Shen; Jianping Chen
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

8.  Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.

Authors:  Sun Kyoung Lee; Kwang-Kyun Park; Ki Rim Kim; Hyun-Jeong Kim; Won-Yoon Chung
Journal:  J Cancer Prev       Date:  2015-12-30

9.  Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation.

Authors:  Neng Wang; Zhiyu Wang; Yu Wang; Xiaoming Xie; Jiangang Shen; Cheng Peng; Jieshu You; Fu Peng; Hailin Tang; Xinyuan Guan; Jianping Chen
Journal:  Oncotarget       Date:  2015

10.  Effects of isoliquiritigenin on ovarian cancer cells.

Authors:  Nan Li; Liang Yang; Xinna Deng; Yanan Sun
Journal:  Onco Targets Ther       Date:  2018-03-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.